Judy Wen
AstraZeneca (Brazil)(BR)AstraZeneca (Switzerland)(CH)
Publications by Year
Research Areas
Respiratory viral infections research, Neonatal Respiratory Health Research, SARS-CoV-2 and COVID-19 Research, Virology and Viral Diseases, Parvovirus B19 Infection Studies
Most-Cited Works
- → Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants(2020)414 cited
- → A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age(2017)95 cited
- → Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein Nanoparticle Vaccine With Matrix-M Adjuvant in Healthy Adults(2019)47 cited
- → A Randomized Phase 1 Clinical Trial of a Respiratory Syncytial Virus and Human Metapneumovirus Combination Protein-Based Virus-like Particle Vaccine in Adults 60–75 Years of Age(2025)19 cited
- → 2637. Third Trimester Immunization with an Respiratory Syncytial Virus F Protein Vaccine for the Prevention of RSV Lower Respiratory Tract Infection in Infants(2019)5 cited
- → P-601. Safety and Immunogenicity of a Respiratory Syncytial Virus and Human Metapneumovirus Virus-like Particle Protein Subunit Combination Vaccine in 60–85-Year-Old Adults: Interim Results from a Phase 2a Clinical Trial(2025)1 cited
- → A first-in-human Phase 1/1b randomized trial evaluating the safety and immunogenicity of a respiratory syncytial virus (RSV) virus-like particle subunit vaccine (IVX-121) in healthy young and older adults(2026)
- → A Phase IIa randomized clinical trial of a respiratory syncytial virus and human metapneumovirus combination protein-based virus-like particle vaccine in adults 60–85 years of age(2026)